Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine-Assisted Goal-Directed Fluid Therapy and Acute Kidney Injury Incidence in Living Donor Liver Transplantation
NCT07885657Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Randomised trial of norepinephrine in acute kidney injury (AKI) (2 arms), sponsored by Mansoura University. Primary endpoint: Incidence of postoperative acute kidney injury at 7 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07885657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07885657.